A leading hospital in Israel, Assuta Medical Center, will host the pilot study of the IOPerfect™, to include up to 400 eyes, a key company milestone.
Menu
A leading hospital in Israel, Assuta Medical Center, will host the pilot study of the IOPerfect™, to include up to 400 eyes, a key company milestone.
Copyright 2022 © Ophthalmic Sciences Ltd. | IOPerfect™ is a trademark of Ophthalmic Sciences Ltd.
Privacy policy | Terms of use | All rights reserved
Our pilot study is underway!
Ophthalmic Sciences is working with Assuta Medical Center in Ashdod and Assuta Hashalom on the study of its novel glaucoma monitoring technology, see our news section for study details.
Contact us for more information.